
Margaret Gamalo
Featured in:
tandfonline.com
Articles
-
Feb 26, 2023 |
tandfonline.com | Robert Nelson |Margaret Gamalo
ABSTRACTPediatric patients should have access to medicines that have been appropriately evaluated for safety and efficacy through revised labelling. Given this goal, the adequacy of the pediatric clinical development plan and resulting safety database are critical factors to inform a favorable benefit-risk assessment for the intended use of the medicinal product.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →